These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25095259)
1. Modeling CD40-based molecular communications in blood vessels. Felicetti L; Femminella M; Reali G; Gresele P; Malvestiti M; Daigle JN IEEE Trans Nanobioscience; 2014 Sep; 13(3):230-43. PubMed ID: 25095259 [TBL] [Abstract][Full Text] [Related]
2. Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake. Giannini S; Falcinelli E; Bury L; Guglielmini G; Rossi R; Momi S; Gresele P Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2072-9. PubMed ID: 21378140 [TBL] [Abstract][Full Text] [Related]
8. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Henn V; Slupsky JR; Gräfe M; Anagnostopoulos I; Förster R; Müller-Berghaus G; Kroczek RA Nature; 1998 Feb; 391(6667):591-4. PubMed ID: 9468137 [TBL] [Abstract][Full Text] [Related]
9. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402 [TBL] [Abstract][Full Text] [Related]
10. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis. Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846 [TBL] [Abstract][Full Text] [Related]
11. Platelet-vessel wall interactions in the microcirculation. Tailor A; Cooper D; Granger DN Microcirculation; 2005; 12(3):275-85. PubMed ID: 15814436 [TBL] [Abstract][Full Text] [Related]
12. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Slupsky JR; Kalbas M; Willuweit A; Henn V; Kroczek RA; Müller-Berghaus G Thromb Haemost; 1998 Dec; 80(6):1008-14. PubMed ID: 9869175 [TBL] [Abstract][Full Text] [Related]
13. CD40/CD40L interaction induces E-selectin dependent leukocyte adhesion to human endothelial cells and inhibits endothelial cell migration. Urban D; Thanabalasingam U; Stibenz D; Kaufmann J; Meyborg H; Fleck E; Gräfe M; Stawowy P Biochem Biophys Res Commun; 2011 Jan; 404(1):448-52. PubMed ID: 21138731 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species. Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185 [TBL] [Abstract][Full Text] [Related]
15. Immune-mediated and lipid-mediated platelet function in atherosclerosis. Ahmadsei M; Lievens D; Weber C; von Hundelshausen P; Gerdes N Curr Opin Lipidol; 2015 Oct; 26(5):438-48. PubMed ID: 26270811 [TBL] [Abstract][Full Text] [Related]